TCR2 Therapeutics Inc.
USD1.48
+0.00 (+0.00%)
CEO
Garry E. Menzel
IPO Date
2019-02-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.58
Prev. Close
$1.48
Day Low
$1.48
Day High
$1.48
52W Low
$0.82
52W High
$3.88
Market Cap
$0.06B
Volume
3.75M
| 4,158,964 |
| $0.00 |
| 5 Jun 2023 | MPM SunStates Fund, L.P. | 10 percent owner | J-Other | Disposed | 4,158,964 | $0.00 |
| 5 Jun 2023 | UBS Oncology Impact Fund L.P. | 10 percent owner | J-Other | Disposed | 3,370,982 | $0.00 |
| 5 Jun 2023 | GADICKE ANSBERT | director, 10 percent owner: | J-Other | Disposed | 3,370,982 | $0.00 |
| 1 Jun 2023 | Tomasello Shawn | director | D-Return | Disposed | 4,177 | $26.33 |
| 1 Jun 2023 | Tomasello Shawn | director | D-Return | Disposed | 16,800 | $0.97 |
| 1 Jun 2023 | Tomasello Shawn | director | D-Return | Disposed | 12,100 | $5.21 |
| 1 Jun 2023 | Webster Stephen W | director | D-Return | Disposed | 16,800 | $0.97 |
| 1 Jun 2023 | Webster Stephen W | director | D-Return | Disposed | 12,100 | $31.83 |